Medscape, LLC

  • Non-alcoholic Fatty Liver Disease

New Horizons in MASH Management

The goal of this activity is for learners to be better able to understand the relationship of metabolic dysfunction-associated steatohepatitis (MASH) pathology and the mechanism of emerging treatments, including data on efficacy and safety for these novel treatment approaches.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Nov 25, 2025
  • Last day to claim credit
    Nov 26, 2026 7 weeks left